{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:59:59Z","timestamp":1771660799938,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11906-022-01169-6","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T13:03:12Z","timestamp":1643115792000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emergency Department Management of Hypertension in the Context of COVID-19"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-418X","authenticated-orcid":false,"given":"Sara W.","family":"Heinert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"1169_CR1","unstructured":"Rui P, Kang K. National Hospital Ambulatory Medical Care Survey: 2017 emergency department summary tables. National Center for Health Statistics.\u00a02020."},{"key":"1169_CR2","first-page":"1","volume":"72","author":"RW Niska","year":"2011","unstructured":"Niska RW. Blood pressure measurements at emergency department visits by adults: United States, 2007\u20132008. NCHS Data Brief. 2011;72:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"11","key":"1169_CR3","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.amjcard.2015.09.007","volume":"116","author":"CD McNaughton","year":"2015","unstructured":"McNaughton CD, Self WH, Zhu Y, Janke AT, Storrow AB, Levy P. Incidence of hypertension-related emergency department visits in the United States, 2006 to 2012. Am J Cardiol. 2015;116(11):1717\u201323.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1169_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.119.14002","volume":"75","author":"P Oras","year":"2020","unstructured":"Oras P, H\u00e4bel H, Skoglund PH, Svensson P. Elevated blood pressure in the emergency department: a risk factor for incident cardiovascular disease. Hypertension. 2020;75(1):229\u201336.","journal-title":"Hypertension"},{"key":"1169_CR5","doi-asserted-by":"crossref","unstructured":"Poon SJ, Roumie CL, O'Shea CJ, et al. Association of elevated blood pressure in the emergency department with chronically elevated blood pressure. J Am Heart Assoc. 2020;9(12):e015985.","DOI":"10.1161\/JAHA.119.015985"},{"issue":"3","key":"1169_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.annemergmed.2007.10.017","volume":"51","author":"P Tanabe","year":"2008","unstructured":"Tanabe P, Persell SD, Adams JG, McCormick JC, Martinovich Z, Baker DW. Increased blood pressure in the emergency department: pain, anxiety, or undiagnosed hypertension? Ann Emerg Med. 2008;51(3):221\u20139.","journal-title":"Ann Emerg Med"},{"issue":"5","key":"1169_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1751-7176.2012.00622.x","volume":"14","author":"KC Ferdinand","year":"2012","unstructured":"Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA, Ferdinand DP. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14(5):336\u201343.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"1169_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MAJ.0000000000000308","volume":"348","author":"DT Lackland","year":"2014","unstructured":"Lackland DT. Racial differences in hypertension: implications for high blood pressure management. Am J Med Sci. 2014;348(2):135\u20138.","journal-title":"Am J Med Sci"},{"key":"1169_CR9","unstructured":"Office of Minority Health. Heart Disease and African Americans. https:\/\/minorityhealth.hhs.gov\/omh\/browse.aspx?lvl=4&lvlid=19. Accessed October 23, 2020."},{"issue":"12","key":"1169_CR10","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","volume":"324","author":"P Muntner","year":"2020","unstructured":"Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999\u20132000 to 2017\u20132018. JAMA. 2020;324(12):1190\u2013200.","journal-title":"JAMA"},{"issue":"12","key":"1169_CR11","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","volume":"360","author":"K Bibbins-Domingo","year":"2009","unstructured":"Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360(12):1179\u201390.","journal-title":"N Engl J Med"},{"key":"1169_CR12","unstructured":"Centers for Disease Control and Prevention. COVID-19 racial and ethnic health disparities. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/community\/health-equity\/racial-ethnic-disparities\/increased-risk-illness.html. Accessed April 20, 2021."},{"issue":"6","key":"1169_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/cid\/ciaa818","volume":"72","author":"GOA Naik","year":"2020","unstructured":"Naik GOA. COVID-19 and the renin-angiotensin-aldosterone system. Clin Infect Dis. 2020;72(6):1105\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1169_CR14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/jch.13925","volume":"22","author":"M Tadic","year":"2020","unstructured":"Tadic M, Cuspidi C, Grassi G, Mancia G. COVID-19 and arterial hypertension: hypothesis or evidence? J Clin Hypertens (Greenwich). 2020;22(7):1120\u20136.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1169_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcvm.2020.00143","volume":"7","author":"A Mascolo","year":"2020","unstructured":"Mascolo A, Scavone C, Rafaniello C, et al. Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review. Front Cardiovasc Med. 2020;7:143. https:\/\/doi.org\/10.3389\/fcvm.2020.00143.","journal-title":"Front Cardiovasc Med"},{"key":"1169_CR16","doi-asserted-by":"crossref","unstructured":"Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.","DOI":"10.1371\/journal.pone.0241265"},{"issue":"5","key":"1169_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531\u20138.","journal-title":"Clin Res Cardiol"},{"key":"1169_CR18","doi-asserted-by":"crossref","unstructured":"Javanmardi F, Keshavarzi A, Akbari A, Emami A, Pirbonyeh N. Prevalence of underlying diseases in died cases of COVID-19: a systematic review and meta-analysis. PLoS One. 2020;15(10):e0241265.","DOI":"10.1371\/journal.pone.0241265"},{"issue":"20","key":"1169_CR19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"key":"1169_CR20","doi-asserted-by":"crossref","unstructured":"Rodilla E, Saura A, Jim\u00e9nez I, et al. Association of hypertension with all-cause mortality among hospitalized patients with COVID-19. J Clin Med. 2020;9(10).","DOI":"10.3390\/jcm9103136"},{"key":"1169_CR21","doi-asserted-by":"crossref","unstructured":"Rodriguez-Morales AJ, Cardona-Ospina JA, Guti\u00e9rrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.","DOI":"10.1016\/j.tmaid.2020.101623"},{"key":"1169_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","volume":"94","author":"J Yang","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91\u20135.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"1169_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","volume":"76","author":"G Iaccarino","year":"2020","unstructured":"Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M. Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020;76(2):366\u201372.","journal-title":"Hypertension"},{"key":"1169_CR24","unstructured":"Barrera FJ, Shekhar S, Wurth R, et al. Prevalence of diabetes and hypertension and their associated risks for poor outcomes in Covid-19 patients. J Endocrinol.\u00a02020;4(9)."},{"issue":"7","key":"1169_CR25","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/aging.103000","volume":"12","author":"B Wang","year":"2020","unstructured":"Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049\u201357.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"1169_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.14336\/AD.2020.0520","volume":"11","author":"T Wu","year":"2020","unstructured":"Wu T, Zuo Z, Kang S, et al. Multi-organ dysfunction in patients with COVID-19: a systematic review and meta-analysis. Aging Dis. 2020;11(4):874\u201394.","journal-title":"Aging Dis"},{"key":"1169_CR27","doi-asserted-by":"crossref","unstructured":"Yanover C, Mizrahi B, Kalkstein N, et al. What factors increase the risk of complications in SARS-CoV-2-infected patients? A cohort study in a Nationwide Israeli Health Organization. JMIR Public Health Surveill. 2020;6(3):e20872.","DOI":"10.2196\/20872"},{"key":"1169_CR28","doi-asserted-by":"crossref","unstructured":"Zhang J, Wu J, Sun X, et al. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: a meta-analysis. Epidemiol Infect. 2020;148:e106.","DOI":"10.1017\/S095026882000117X"},{"issue":"2","key":"1169_CR29","doi-asserted-by":"publisher","first-page":"147032032092689","DOI":"10.1177\/1470320320926899","volume":"21","author":"R Pranata","year":"2020","unstructured":"Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin Angiotensin Aldosterone Syst. 2020;21(2):1470320320926899.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"10","key":"1169_CR30","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/acem.14104","volume":"27","author":"M Gottlieb","year":"2020","unstructured":"Gottlieb M, Sansom S, Frankenberger C, Ward E, Hota B. Clinical course and factors associated with hospitalization and critical illness among COVID-19 patients in Chicago. Illinois Acad Emerg Med. 2020;27(10):963\u201373.","journal-title":"Illinois Acad Emerg Med"},{"key":"1169_CR31","doi-asserted-by":"crossref","unstructured":"Chidambaram V, Tun NL, Haque WZ, et al. Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis. PLoS One. 2020;15(11):e0241541.","DOI":"10.1371\/journal.pone.0241541"},{"key":"1169_CR32","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. This systematic review and meta analysis describes the association of pre-existing comorbidities and COVID-19 mortality, with hypertension having significantly greater risk of mortality from COVID-19.","DOI":"10.1371\/journal.pone.0238215"},{"issue":"2","key":"1169_CR33","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16\u201325.","journal-title":"J Infect"},{"issue":"8","key":"1169_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41440-020-0485-2","volume":"43","author":"S Huang","year":"2020","unstructured":"Huang S, Wang J, Liu F, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020;43(8):824\u201331.","journal-title":"Hypertens Res"},{"issue":"1","key":"1169_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5334\/gh.814","volume":"15","author":"K Matsushita","year":"2020","unstructured":"Matsushita K, Ding N, Kou M, et al. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis. Glob Heart. 2020;15(1):64.","journal-title":"Glob Heart"},{"issue":"1","key":"1169_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12872-020-01816-3","volume":"21","author":"A Silverio","year":"2021","unstructured":"Silverio A, Di Maio M, Citro R, et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc Disord. 2021;21(1):23.","journal-title":"BMC Cardiovasc Disord"},{"issue":"15","key":"1169_CR37","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/cid\/ciaa242","volume":"71","author":"J Lian","year":"2020","unstructured":"Lian J, Jin X, Hao S, et al. Analysis of epidemiological and clinical features in older patients with coronavirus diseaSe 2019 (COVID-19) outside Wuhan. Clin Infect Dis. 2020;71(15):740\u20137.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1169_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","volume":"5","author":"J Li","year":"2020","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan. China JAMA Cardiol. 2020;5(7):825\u201330.","journal-title":"China JAMA Cardiol"},{"key":"1169_CR39","unstructured":"Centers for Disease Control and Prevention. Underlying medical conditions associated with high risk for severe COVID-19: information for healthcare providers. March 29, 2021; https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html. Accessed April 12, 2021."},{"issue":"2","key":"1169_CR40","first-page":"e13","volume":"76","author":"X Guo","year":"2020","unstructured":"Guo X, Zhu Y, Hong Y. Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension: a meta-analysis. Hypertension. 2020;76(2):e13\u20134.","journal-title":"Hypertension"},{"issue":"19","key":"1169_CR41","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","volume":"106","author":"ME Flacco","year":"2020","unstructured":"Flacco ME, Acuti Martellucci C, Bravi F, et al. Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis. Heart. 2020;106(19):1519\u201324.","journal-title":"Heart"},{"issue":"10","key":"1169_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11883-020-00880-6","volume":"22","author":"R Baral","year":"2020","unstructured":"Baral R, White M, Vassiliou VS. Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients. Curr Atheroscler Rep. 2020;22(10):61.","journal-title":"Curr Atheroscler Rep"},{"key":"1169_CR43","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Ren L, Yu S, Xu W, Overton JL, Chiamvimonvat N, Thai PN. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. J Cardiol. 2021;77(5):482\u2013491. This meta-analysis of 53 studies finds no association between prior use of antihypertensive medications and risk and severity of COVID-19. For patients with hypertension, severity and mortality from COVID-19 were lower with prior use of ACE-i\/ARB.","DOI":"10.1016\/j.jjcc.2020.10.015"},{"key":"1169_CR44","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Network Open. 2020;3(12):e2029058\u2013e2029058. This US national sample of patients with COVID-19 analyzes univariate and multivariate risk factors, including HTN, for in-hospital mortality. Authors also found that ACE-is were associated with decreased odds of death.","DOI":"10.1001\/jamanetworkopen.2020.29058"},{"issue":"1","key":"1169_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.annemergmed.2013.05.012","volume":"62","author":"SJ Wolf","year":"2013","unstructured":"Wolf SJ, Lo B, Shih RD, Smith MD, Fesmire FM. Clinical policy: critical issues in the evaluation and management of adult patients in the emergency department with asymptomatic elevated blood pressure. Ann Emerg Med. 2013;62(1):59\u201368.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"1169_CR46","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1001\/jama.2010.1112","volume":"304","author":"N Tang","year":"2010","unstructured":"Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R. Trends and characteristics of US emergency department visits, 1997\u20132007. JAMA. 2010;304(6):664\u201370.","journal-title":"JAMA"},{"issue":"15","key":"1169_CR47","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1001\/archinte.168.15.1705","volume":"168","author":"G Rust","year":"2008","unstructured":"Rust G, Ye J, Baltrus P, Daniels E, Adesunloye B, Fryer GE. Practical barriers to timely primary care access: impact on adult use of emergency department services. Arch Intern Med. 2008;168(15):1705\u201310.","journal-title":"Arch Intern Med"},{"key":"1169_CR48","doi-asserted-by":"crossref","unstructured":"Lau D, McAlister FA. Implications of the COVID-19 pandemic for cardiovascular disease and risk-factor management. Can J Cardiol. 2020.","DOI":"10.1016\/j.cjca.2020.11.001"},{"issue":"2","key":"1169_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jemermed.2019.12.005","volume":"58","author":"SD Cornell","year":"2020","unstructured":"Cornell SD, Valerio MA, Krause T, Cornell J, Revere L, Taylor BS. Low adherence to post emergency department follow-up among hypertensive patients with medical insurance. J Emerg Med. 2020;58(2):348\u201355.","journal-title":"J Emerg Med"},{"key":"1169_CR50","doi-asserted-by":"crossref","unstructured":"Loerinc LB, Scheel AM, Evans ST, Shabto JM, O'Keefe GA, O'Keefe JB. Discharge characteristics and care transitions of hospitalized patients with COVID-19. Healthcare. 2021;9(1):100512.","DOI":"10.1016\/j.hjdsi.2020.100512"},{"issue":"23","key":"1169_CR51","doi-asserted-by":"publisher","first-page":"699","DOI":"10.15585\/mmwr.mm6923e1","volume":"69","author":"KP Hartnett","year":"2020","unstructured":"Hartnett KP, Kite-Powell A, DeVies J, et al. Impact of the COVID-19 pandemic on emergency department visits - United States, January 1, 2019-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(23):699\u2013704.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1169_CR52","doi-asserted-by":"crossref","unstructured":"Cantor JH, McBain RK, Pera MF, Bravata DM, Whaley CM. Who is (and is not) receiving telemedicine care during the COVID-19 pandemic. Am J Prev Med. 2021.","DOI":"10.1016\/j.amepre.2021.01.030"},{"issue":"15","key":"1169_CR53","doi-asserted-by":"publisher","first-page":"552","DOI":"10.15585\/mmwr.mm7015a3","volume":"70","author":"J Adjemian","year":"2021","unstructured":"Adjemian J, Hartnett KP, Kite-Powell A, et al. Update: COVID-19 pandemic-associated changes in emergency department visits - United States, December 2020-January 2021. MMWR Morb Mortal Wkly Rep. 2021;70(15):552\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1169_CR54","unstructured":"Mehrotra A, Chernew M, Linetsky D, Hatch H, Cutler D, Schneider E. The impact of the COVID-19 pandemic on outpatient visits: changing patterns of care in the newest COVID-19 hot spots. The Commonwealth Fund.\u00a02020."},{"key":"1169_CR55","doi-asserted-by":"crossref","unstructured":"Patel S, Lorenzi N, Smith T, Carlson BR, Sternberg Jr P. Critical insights from patients during the COVID-19 pandemic. NEJM Catalyst Innovations in Care Delivery. 2020;1(4).","DOI":"10.1056\/CAT.19.1111"},{"key":"1169_CR56","unstructured":"\u2022 Jarrard Phillips Cate & Hancock & Public Opinions Strategies. Executive summary: coronavirus and its impact on us healthcare providers. April 2020. https:\/\/pos.org\/wp-content\/uploads\/2020\/04\/Jarrard-POS-National-Survey-Exec-Summary-4-29-2020.pdf. Accessed July 23, 2021. This report describes findings from a national online survey of 1000 adults on reasons for missed healthcare visits, what would make people feel safer about going to a medical facility, and use of and satisfaction with telehealth."},{"key":"1169_CR57","doi-asserted-by":"crossref","unstructured":"Woolhandler S, Himmelstein DU. Intersecting U.S. epidemics: COVID-19 and lack of health insurance. Ann Intern Med. 2020;173(1):63\u201364.","DOI":"10.7326\/M20-1491"},{"key":"1169_CR58","unstructured":"\u2022 American College of Emergency Physicians & Morning Consult. American College of Emergency Physicians: COVID-19. April 2020. https:\/\/www.emergencyphysicians.org\/globalassets\/emphysicians\/all-pdfs\/acep-mc-covid19-april-poll-analysis.pdf. Accessed July 23, 2021. This report describes findings on a survey of 2,200 adults on their concerns about obtaining emergency care."},{"key":"1169_CR59","doi-asserted-by":"crossref","unstructured":"Patel P, Dhindsa D, Eapen DJ, et al. Optimizing the potential for telehealth in cardiovascular care (in the era of COVID-19): time will tell. Am J Med. 2021.","DOI":"10.1016\/j.amjmed.2021.03.007"},{"key":"1169_CR60","doi-asserted-by":"crossref","unstructured":"Aashima, Nanda M, Sharma R. A review of patient satisfaction and experience with telemedicine: a virtual solution during and beyond COVID-19 pandemic. Telemedicine and e-Health. 2021.","DOI":"10.1089\/tmj.2020.0570"},{"key":"1169_CR61","doi-asserted-by":"crossref","unstructured":"Andrews E, Berghofer K, Long J, Prescott A, Caboral-Stevens M. Satisfaction with the use of telehealth during COVID-19: an integrative review.\u00a0Int J Nurs Stud. 2020;2:100008.","DOI":"10.1016\/j.ijnsa.2020.100008"},{"issue":"11","key":"1169_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11882-020-00969-7","volume":"20","author":"M Nguyen","year":"2020","unstructured":"Nguyen M, Waller M, Pandya A, Portnoy J. A review of patient and provider satisfaction with telemedicine. Curr Allergy Asthma Rep. 2020;20(11):72.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1169_CR63","doi-asserted-by":"crossref","unstructured":"Brown KJ, Mathenge N, Crousillat D, et al. Social determinants of telemedicine utilization in ambulatory cardiovascular patients during the COVID-19 pandemic.\u00a0EHJDH. 2021.","DOI":"10.1016\/S0735-1097(21)04528-9"},{"key":"1169_CR64","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Eberly LA, Kallan MJ, Julien HM, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12):e2031640-e2031640. This study of 148,402 patients found inequities in accessing telemedicine and discusses groups of patients with lower rates of telemedicine use.","DOI":"10.1001\/jamanetworkopen.2020.31640"},{"issue":"4","key":"1169_CR65","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1007\/s11606-020-06544-0","volume":"36","author":"P Kakani","year":"2021","unstructured":"Kakani P, Sorensen A, Quinton JK, et al. Patient characteristics associated with telemedicine use at a large academic health system before and after COVID-19. J Gen Intern Med. 2021;36(4):1166\u20138.","journal-title":"J Gen Intern Med"},{"key":"1169_CR66","doi-asserted-by":"crossref","unstructured":"Drake C, Lian T, Cameron B, Medynskaya K, Bosworth HB, Shah K. Understanding telemedicine's \u201cnew normal\u201d: variations in telemedicine use by specialty line and patient demographics. Telemedicine and e-Health. 2021.","DOI":"10.1089\/tmj.2021.0041"},{"issue":"3","key":"1169_CR67","doi-asserted-by":"publisher","first-page":"e212618","DOI":"10.1001\/jamanetworkopen.2021.2618","volume":"4","author":"JP Weiner","year":"2021","unstructured":"Weiner JP, Bandeian S, Hatef E, Lans D, Liu A, Lemke KW. In-person and telehealth ambulatory contacts and costs in a large US insured cohort before and during the COVID-19 pandemic. JAMA Netw Open. 2021;4(3):e212618\u2013e212618.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1169_CR68","doi-asserted-by":"publisher","first-page":"e214157","DOI":"10.1001\/jamanetworkopen.2021.4157","volume":"4","author":"N Yuan","year":"2021","unstructured":"Yuan N, Pevnick JM, Botting PG, et al. Patient use and clinical practice patterns of remote cardiology clinic visits in the era of COVID-19. JAMA Netw Open. 2021;4(4):e214157\u2013e214157.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1169_CR69","doi-asserted-by":"publisher","first-page":"e2021476","DOI":"10.1001\/jamanetworkopen.2020.21476","volume":"3","author":"GC Alexander","year":"2020","unstructured":"Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and content of primary care office-based vs telemedicine care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(10):e2021476\u2013e2021476.","journal-title":"JAMA Netw Open"},{"issue":"Supplement","key":"1169_CR70","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.3122\/jabfm.2021.S1.200247","volume":"34","author":"Y Jabbarpour","year":"2021","unstructured":"Jabbarpour Y, Jetty A, Westfall M, Westfall J. Not telehealth: which primary care visits need in-person care? J Am Board Fam Med. 2021;34(Supplement):S162\u20139.","journal-title":"J Am Board Fam Med"},{"issue":"6","key":"1169_CR71","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1056\/NEJMp2008017","volume":"383","author":"B Pfefferbaum","year":"2020","unstructured":"Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med. 2020;383(6):510\u20132.","journal-title":"N Engl J Med"},{"key":"1169_CR72","doi-asserted-by":"crossref","unstructured":"Liao JM, Pronovost PJ, Navathe AS. To re-open health care, leaders should address patient fear. NEJM Catalyst Innovations in Care Delivery. 2020;1(4).","DOI":"10.1056\/CAT.19.1111"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01169-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-022-01169-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-022-01169-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T18:05:26Z","timestamp":1645293926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-022-01169-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1169"],"URL":"https:\/\/doi.org\/10.1007\/s11906-022-01169-6","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,25]]},"assertion":[{"value":"15 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sara Heinert, Renee Riggs, and Heather Prendergast declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}